Lincoln Pharmaceuticals launches cough syrup ‘NAMCOLD-DX’

13 Aug 2015 Evaluate

Lincoln Pharmaceuticals has successfully launched a cough syrup ‘NAMCOLD-DX’, which contains Dextromethorphan Polistirex. This is an Extended Release, unique product of Novel Technology. ‘NAMCOLD-DX’ is designed for all age group of patient above 4 years. The product is time tested and many trials have been done and it is approved by Drug Controller General of India (DCGI).

Normal cough syrups are effective up to 3-4 hours, so in 24 hours the patient has to take the syrup 4 to 5 times. But, this innovative product ‘NAMCOLD-DX’ is extended release, so the drug releases periodically and therefore the patient has to take only 2 doses during 24 hours.

Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.


Lincoln Pharma Share Price

599.90 18.85 (3.24%)
24-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.50
Dr. Reddys Lab 1201.45
Cipla 1551.30
Lupin 2104.90
Zydus Lifesciences 879.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...